Discover how Carevix® is paving the way for safer, pain-reduced gynecological procedures—because every woman deserves care that feels considerate.

‎

A Century-Old Problem—Finally Solved

For over 100 years, gynecological procedures like IUD insertions have relied on the cervical tenaculum—a sharp, forceps-like instrument that grips the cervix but often causes significant pain and bleeding. Shockingly, up to 90% of women report mild to severe discomfort during procedures with this tool—and around 18% even avoid IUDs entirely out of fear of pain.

‎

Meet Carevix®—Gentle by Design

Aspivix is changing the narrative with Carevix®, a soft-suction, vacuum-based cervical stabilizer that offers a modern, trauma-free alternative. Rather than piercing tissue, it gently affixes to the cervix via suction, significantly reducing pain and bleeding—while preserving clinical effectiveness.

‎

Clinically Proven—from Trials to Regulatory Approval

ADVANCE Women Trial: In a randomized controlled study (published in Contraception, March 2023), Carevix® achieved up to 73% reduction in pain scores and 78% fewer bleeding events compared to the tenaculum.

‎

Regulatory Clearances:

• FDA 510(k) clearance granted in January 2023 ([Aspivix][3]).
• CE Mark approval awarded in December 2023, enabling usage across Europe.

‎

Real-World Impact—Comfort You Can Feel

First US Implementation: In May 2024, Carevix® was used for the first time during gynecological procedures in the U.S., where clinicians noted less bleeding, shorter procedure time, and reports of “essentially no pain” from patients.

‎

Tia Clinics Roll-Out:

Through an innovative partnership, Carevix® was introduced in 9 Tia women’s health clinics across major U.S. cities by late 2024. Over 700 patients globally have experienced markedly improved comfort—over 90% reported satisfaction in procedures including IUDs, hysteroscopy, and fertility-related exams.

‎

Why This Matters to You

• Pay-by-pain, not procedure: A less painful experience means more women may feel empowered to pursue IUDs and other preventive procedures they need.
• Confidence in protection: IUDs are 99% effective. Removing pain as a barrier could increase adoption—supporting contraceptive autonomy and reducing unintended pregnancies.
• Human-centered care is trending: Carevix® exemplifies the shift toward empathetic, patient-first gynecology.

‎

Looking Ahead

Carevix® is now commercially available in the U.S., Europe, U.K., and Brazil. With growing adoption and strong clinical evidence behind it, the device stands poised to transform transcervical gynecological care globally.

‎

Your Next Steps

• Read patient stories: Join Aspivix’s blog posts like “A New Tool Could Make IUD Insertions Less Painful” for heartfelt testimonials.
• Ask your provider: If you’re considering an IUD or related procedure, ask whether Carevix® is available—it may offer a gentler alternative.
• Curve the fear: Understand that pain doesn’t have to be part of your gynecological care-and there are modern options now.

‎

Carevix® by Aspivix isn’t just a medical device—it’s a meaningful leap forward in women’s health. It’s proof that care can—and should—be gentle, respectful, and effective.